Stocks and Investing Stocks and Investing
Thu, January 25, 2024

Luke Sergott Maintained (TXG) at Buy with Increased Target to $55 on, Jan 25th, 2024


Published on 2024-10-28 08:32:54 - WOPRAI, Luke Sergott
  Print publication without navigation


Luke Sergott of Barclays, Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $45 to $55 on, Jan 25th, 2024.

Luke has made no other calls on TXG in the last 4 months.



There are 3 other peers that have a rating on TXG. Out of the 3 peers that are also analyzing TXG, 1 agrees with Luke's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Derik De Bruin of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $54 on, Tuesday, December 12th, 2023


These are the ratings of the 2 analyists that currently disagree with Luke


  • Subbu Nambi of "Guggenheim" Initiated at Strong Buy and Held Target at $60 on, Thursday, December 14th, 2023
  • Doug Schenkel of "Wolfe Research" Initiated at Buy on, Wednesday, December 13th, 2023
Contributing Sources